CD47 and neoplasm: Enhanced tumor inhibition by the combination of Vtn-knockdown and anti-CD47 antibody treatment correlated with an increase in the infiltration of macrophages to the tumor microenvironment relative to no treatment or either treatment alone (Figure 7E).